Structure

Physi-Chem Properties

Molecular Weight:  368.13
Volume:  375.116
LogP:  5.233
LogD:  3.365
LogS:  -3.664
# Rotatable Bonds:  5
TPSA:  100.13
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.451
Synthetic Accessibility Score:  3.033
Fsp3:  0.19
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.921
MDCK Permeability:  1.1587204426177777e-05
Pgp-inhibitor:  0.016
Pgp-substrate:  0.288
Human Intestinal Absorption (HIA):  0.031
20% Bioavailability (F20%):  0.765
30% Bioavailability (F30%):  0.949

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.002
Plasma Protein Binding (PPB):  96.28888702392578%
Volume Distribution (VD):  0.706
Pgp-substrate:  4.776064872741699%

ADMET: Metabolism

CYP1A2-inhibitor:  0.898
CYP1A2-substrate:  0.405
CYP2C19-inhibitor:  0.806
CYP2C19-substrate:  0.061
CYP2C9-inhibitor:  0.832
CYP2C9-substrate:  0.919
CYP2D6-inhibitor:  0.835
CYP2D6-substrate:  0.456
CYP3A4-inhibitor:  0.518
CYP3A4-substrate:  0.1

ADMET: Excretion

Clearance (CL):  10.386
Half-life (T1/2):  0.605

ADMET: Toxicity

hERG Blockers:  0.006
Human Hepatotoxicity (H-HT):  0.534
Drug-inuced Liver Injury (DILI):  0.942
AMES Toxicity:  0.585
Rat Oral Acute Toxicity:  0.07
Maximum Recommended Daily Dose:  0.582
Skin Sensitization:  0.184
Carcinogencity:  0.178
Eye Corrosion:  0.003
Eye Irritation:  0.785
Respiratory Toxicity:  0.431

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC247677

Natural Product ID:  NPC247677
Common Name*:   Ebenfuran Iii
IUPAC Name:   2-(2,4-dihydroxyphenyl)-4-hydroxy-6-methoxy-5-(3-methylbut-2-enyl)-1-benzofuran-3-carbaldehyde
Synonyms:   Ebenfuran III
Standard InCHIKey:  PXSWSGDFRGTMGP-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C21H20O6/c1-11(2)4-6-14-17(26-3)9-18-19(20(14)25)15(10-22)21(27-18)13-7-5-12(23)8-16(13)24/h4-5,7-10,23-25H,6H2,1-3H3
SMILES:  O=Cc1c(oc2c1c(O)c(c(c2)OC)CC=C(C)C)c1ccc(cc1O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL579049
PubChem CID:   10090417
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12804 Onobrychis ebenoides Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[11141112]
NPO12804 Onobrychis ebenoides Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[18986200]
NPO12804 Onobrychis ebenoides Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens EC50 = 2600.0 nM PMID[513992]
NPT83 Cell Line MCF7 Homo sapiens Activity = 47.0 % PMID[513992]
NPT83 Cell Line MCF7 Homo sapiens EC50 = 2900.0 nM PMID[513992]
NPT83 Cell Line MCF7 Homo sapiens Activity = 31.0 % PMID[513992]
NPT108 Individual Protein Estrogen receptor alpha Homo sapiens RBA = 0.09 n.a. PMID[513992]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC247677 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC160015
0.9933 High Similarity NPC296957
0.9933 High Similarity NPC260902
0.9867 High Similarity NPC476350
0.9867 High Similarity NPC476349
0.9797 High Similarity NPC67654
0.973 High Similarity NPC156244
0.96 High Similarity NPC1477
0.96 High Similarity NPC213608
0.9595 High Similarity NPC37226
0.9595 High Similarity NPC226644
0.9533 High Similarity NPC5871
0.9533 High Similarity NPC263676
0.9527 High Similarity NPC135325
0.947 High Similarity NPC122365
0.9467 High Similarity NPC170169
0.9467 High Similarity NPC116604
0.9463 High Similarity NPC296030
0.9463 High Similarity NPC39929
0.9459 High Similarity NPC12148
0.9459 High Similarity NPC130581
0.9416 High Similarity NPC260296
0.9416 High Similarity NPC115432
0.9412 High Similarity NPC65504
0.9408 High Similarity NPC148938
0.9408 High Similarity NPC198490
0.94 High Similarity NPC78335
0.94 High Similarity NPC230713
0.9392 High Similarity NPC300267
0.9392 High Similarity NPC210826
0.9392 High Similarity NPC51641
0.9351 High Similarity NPC40583
0.9351 High Similarity NPC244750
0.9342 High Similarity NPC183874
0.9342 High Similarity NPC235333
0.9333 High Similarity NPC178202
0.9324 High Similarity NPC230943
0.9299 High Similarity NPC136641
0.9286 High Similarity NPC96342
0.9286 High Similarity NPC246647
0.9286 High Similarity NPC212967
0.9286 High Similarity NPC164110
0.9281 High Similarity NPC297531
0.9281 High Similarity NPC213936
0.9276 High Similarity NPC253872
0.9276 High Similarity NPC207624
0.9272 High Similarity NPC472406
0.9257 High Similarity NPC302181
0.9257 High Similarity NPC225884
0.9236 High Similarity NPC155640
0.9236 High Similarity NPC38591
0.9231 High Similarity NPC304387
0.9226 High Similarity NPC472877
0.9221 High Similarity NPC180924
0.9216 High Similarity NPC472462
0.9211 High Similarity NPC58668
0.9211 High Similarity NPC193976
0.9211 High Similarity NPC23668
0.9211 High Similarity NPC106372
0.9211 High Similarity NPC115324
0.9205 High Similarity NPC221868
0.9205 High Similarity NPC317492
0.9205 High Similarity NPC37208
0.92 High Similarity NPC198427
0.92 High Similarity NPC17816
0.9189 High Similarity NPC53192
0.9177 High Similarity NPC291110
0.9172 High Similarity NPC193998
0.9161 High Similarity NPC270044
0.9161 High Similarity NPC268360
0.9161 High Similarity NPC269495
0.915 High Similarity NPC142308
0.9145 High Similarity NPC135303
0.9145 High Similarity NPC167576
0.9145 High Similarity NPC148423
0.9139 High Similarity NPC272194
0.9139 High Similarity NPC39195
0.9139 High Similarity NPC168085
0.9091 High Similarity NPC42458
0.9091 High Similarity NPC158261
0.9073 High Similarity NPC308200
0.9068 High Similarity NPC131866
0.9068 High Similarity NPC120220
0.9067 High Similarity NPC155144
0.9067 High Similarity NPC98926
0.9062 High Similarity NPC320789
0.906 High Similarity NPC470636
0.906 High Similarity NPC226942
0.906 High Similarity NPC96791
0.9051 High Similarity NPC219861
0.9045 High Similarity NPC220582
0.9045 High Similarity NPC304839
0.9032 High Similarity NPC99199
0.9032 High Similarity NPC474542
0.9026 High Similarity NPC38361
0.9026 High Similarity NPC41326
0.9026 High Similarity NPC130015
0.902 High Similarity NPC321896
0.902 High Similarity NPC476185
0.902 High Similarity NPC155882
0.902 High Similarity NPC472421
0.902 High Similarity NPC191104
0.9013 High Similarity NPC306788
0.9013 High Similarity NPC145467
0.9012 High Similarity NPC472584
0.9007 High Similarity NPC190572
0.9007 High Similarity NPC299011
0.9006 High Similarity NPC53252
0.9 High Similarity NPC53640
0.9 High Similarity NPC277480
0.8994 High Similarity NPC472581
0.8994 High Similarity NPC109180
0.8987 High Similarity NPC74854
0.8987 High Similarity NPC30655
0.8987 High Similarity NPC45124
0.8974 High Similarity NPC474386
0.8968 High Similarity NPC72370
0.8968 High Similarity NPC41719
0.8961 High Similarity NPC474744
0.8961 High Similarity NPC472407
0.8961 High Similarity NPC318424
0.8961 High Similarity NPC474772
0.8961 High Similarity NPC472423
0.8954 High Similarity NPC471114
0.8954 High Similarity NPC88445
0.8944 High Similarity NPC476459
0.8944 High Similarity NPC247973
0.8944 High Similarity NPC50394
0.894 High Similarity NPC271288
0.894 High Similarity NPC311144
0.894 High Similarity NPC311741
0.894 High Similarity NPC234629
0.894 High Similarity NPC303185
0.894 High Similarity NPC184649
0.8938 High Similarity NPC37183
0.8938 High Similarity NPC38914
0.8924 High Similarity NPC49009
0.8924 High Similarity NPC169
0.8919 High Similarity NPC471620
0.8919 High Similarity NPC124269
0.891 High Similarity NPC233776
0.8903 High Similarity NPC473996
0.8903 High Similarity NPC327269
0.8903 High Similarity NPC476238
0.8903 High Similarity NPC31627
0.8896 High Similarity NPC29777
0.8896 High Similarity NPC13282
0.8896 High Similarity NPC471115
0.8889 High Similarity NPC266572
0.8882 High Similarity NPC323137
0.8882 High Similarity NPC477955
0.8882 High Similarity NPC472629
0.8882 High Similarity NPC73320
0.8874 High Similarity NPC169591
0.8874 High Similarity NPC75049
0.8874 High Similarity NPC68104
0.8874 High Similarity NPC150408
0.8874 High Similarity NPC172182
0.8874 High Similarity NPC310130
0.8874 High Similarity NPC106985
0.8874 High Similarity NPC257097
0.8874 High Similarity NPC262935
0.8874 High Similarity NPC164980
0.8874 High Similarity NPC251182
0.8874 High Similarity NPC221432
0.8874 High Similarity NPC175504
0.8874 High Similarity NPC113770
0.8874 High Similarity NPC91560
0.8874 High Similarity NPC39329
0.8874 High Similarity NPC166138
0.8874 High Similarity NPC17262
0.8874 High Similarity NPC149026
0.8874 High Similarity NPC18585
0.8874 High Similarity NPC143896
0.8868 High Similarity NPC472346
0.8868 High Similarity NPC14822
0.8867 High Similarity NPC52789
0.8867 High Similarity NPC3188
0.8867 High Similarity NPC110969
0.8867 High Similarity NPC268204
0.8867 High Similarity NPC321980
0.8867 High Similarity NPC55832
0.8867 High Similarity NPC26051
0.8867 High Similarity NPC470087
0.8867 High Similarity NPC470089
0.8867 High Similarity NPC469404
0.8859 High Similarity NPC477956
0.8859 High Similarity NPC137009
0.8854 High Similarity NPC137100
0.8854 High Similarity NPC13879
0.8851 High Similarity NPC62735
0.8851 High Similarity NPC188879
0.8851 High Similarity NPC472419
0.8841 High Similarity NPC261471
0.8839 High Similarity NPC471675
0.8839 High Similarity NPC472580
0.8839 High Similarity NPC472636
0.8831 High Similarity NPC266499
0.8831 High Similarity NPC214493
0.8827 High Similarity NPC241820

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC247677 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8851 High Similarity NPD2344 Approved
0.8824 High Similarity NPD920 Approved
0.8816 High Similarity NPD4378 Clinical (unspecified phase)
0.8693 High Similarity NPD642 Clinical (unspecified phase)
0.8618 High Similarity NPD2309 Approved
0.8609 High Similarity NPD2800 Approved
0.8571 High Similarity NPD7410 Clinical (unspecified phase)
0.8562 High Similarity NPD3749 Approved
0.8562 High Similarity NPD643 Clinical (unspecified phase)
0.8553 High Similarity NPD8443 Clinical (unspecified phase)
0.8543 High Similarity NPD1549 Phase 2
0.8503 High Similarity NPD6559 Discontinued
0.8491 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8481 Intermediate Similarity NPD7411 Suspended
0.8477 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8477 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8467 Intermediate Similarity NPD1510 Phase 2
0.8446 Intermediate Similarity NPD1240 Approved
0.8418 Intermediate Similarity NPD4380 Phase 2
0.8411 Intermediate Similarity NPD2796 Approved
0.8385 Intermediate Similarity NPD7768 Phase 2
0.8385 Intermediate Similarity NPD3882 Suspended
0.8375 Intermediate Similarity NPD7819 Suspended
0.8366 Intermediate Similarity NPD1243 Approved
0.8364 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8355 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD1607 Approved
0.8333 Intermediate Similarity NPD7075 Discontinued
0.8303 Intermediate Similarity NPD3926 Phase 2
0.8293 Intermediate Similarity NPD1247 Approved
0.8293 Intermediate Similarity NPD6959 Discontinued
0.8261 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8232 Intermediate Similarity NPD5494 Approved
0.8217 Intermediate Similarity NPD2533 Approved
0.8217 Intermediate Similarity NPD2534 Approved
0.8217 Intermediate Similarity NPD2532 Approved
0.8199 Intermediate Similarity NPD1934 Approved
0.8171 Intermediate Similarity NPD919 Approved
0.817 Intermediate Similarity NPD1551 Phase 2
0.8153 Intermediate Similarity NPD6799 Approved
0.8148 Intermediate Similarity NPD2801 Approved
0.8133 Intermediate Similarity NPD6232 Discontinued
0.8129 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.811 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD7473 Discontinued
0.8086 Intermediate Similarity NPD6801 Discontinued
0.8075 Intermediate Similarity NPD6599 Discontinued
0.8047 Intermediate Similarity NPD3818 Discontinued
0.8038 Intermediate Similarity NPD1511 Approved
0.8012 Intermediate Similarity NPD5953 Discontinued
0.7988 Intermediate Similarity NPD2296 Approved
0.7987 Intermediate Similarity NPD2799 Discontinued
0.7962 Intermediate Similarity NPD3750 Approved
0.7941 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7937 Intermediate Similarity NPD1512 Approved
0.7935 Intermediate Similarity NPD2935 Discontinued
0.7929 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD6166 Phase 2
0.7919 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD7286 Phase 2
0.7866 Intermediate Similarity NPD6280 Approved
0.7866 Intermediate Similarity NPD6279 Approved
0.7857 Intermediate Similarity NPD6651 Approved
0.7848 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7834 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD5844 Phase 1
0.7791 Intermediate Similarity NPD3226 Approved
0.7771 Intermediate Similarity NPD3817 Phase 2
0.7771 Intermediate Similarity NPD1471 Phase 3
0.7756 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7712 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7712 Intermediate Similarity NPD2313 Discontinued
0.7706 Intermediate Similarity NPD6808 Phase 2
0.7644 Intermediate Similarity NPD7074 Phase 3
0.7643 Intermediate Similarity NPD3748 Approved
0.764 Intermediate Similarity NPD8434 Phase 2
0.7625 Intermediate Similarity NPD4628 Phase 3
0.7605 Intermediate Similarity NPD5761 Phase 2
0.7605 Intermediate Similarity NPD5760 Phase 2
0.7602 Intermediate Similarity NPD5710 Approved
0.7602 Intermediate Similarity NPD5711 Approved
0.7602 Intermediate Similarity NPD7229 Phase 3
0.7593 Intermediate Similarity NPD7390 Discontinued
0.7586 Intermediate Similarity NPD7054 Approved
0.7582 Intermediate Similarity NPD4908 Phase 1
0.7561 Intermediate Similarity NPD5403 Approved
0.756 Intermediate Similarity NPD5402 Approved
0.7556 Intermediate Similarity NPD4287 Approved
0.7547 Intermediate Similarity NPD2346 Discontinued
0.7543 Intermediate Similarity NPD1729 Discontinued
0.7543 Intermediate Similarity NPD7472 Approved
0.75 Intermediate Similarity NPD1203 Approved
0.75 Intermediate Similarity NPD943 Approved
0.75 Intermediate Similarity NPD6797 Phase 2
0.7468 Intermediate Similarity NPD6832 Phase 2
0.7458 Intermediate Similarity NPD7251 Discontinued
0.7446 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7446 Intermediate Similarity NPD4361 Phase 2
0.7439 Intermediate Similarity NPD5401 Approved
0.7416 Intermediate Similarity NPD7808 Phase 3
0.7416 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7401 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD1465 Phase 2
0.7391 Intermediate Similarity NPD4360 Phase 2
0.7391 Intermediate Similarity NPD4363 Phase 3
0.7375 Intermediate Similarity NPD6100 Approved
0.7375 Intermediate Similarity NPD6099 Approved
0.7372 Intermediate Similarity NPD3764 Approved
0.7351 Intermediate Similarity NPD1610 Phase 2
0.7351 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD2654 Approved
0.7338 Intermediate Similarity NPD2798 Approved
0.7333 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD7033 Discontinued
0.7303 Intermediate Similarity NPD9717 Approved
0.7303 Intermediate Similarity NPD3972 Approved
0.7301 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD3268 Approved
0.7233 Intermediate Similarity NPD230 Phase 1
0.7233 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD3751 Discontinued
0.7225 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD2403 Approved
0.7216 Intermediate Similarity NPD4575 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD1876 Approved
0.72 Intermediate Similarity NPD1548 Phase 1
0.7197 Intermediate Similarity NPD4625 Phase 3
0.7196 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD7003 Approved
0.7189 Intermediate Similarity NPD3269 Clinical (unspecified phase)
0.7182 Intermediate Similarity NPD8313 Approved
0.7182 Intermediate Similarity NPD8312 Approved
0.7174 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD1470 Approved
0.7161 Intermediate Similarity NPD1164 Approved
0.7161 Intermediate Similarity NPD2797 Approved
0.716 Intermediate Similarity NPD5405 Approved
0.716 Intermediate Similarity NPD7458 Discontinued
0.716 Intermediate Similarity NPD5408 Approved
0.716 Intermediate Similarity NPD5406 Approved
0.716 Intermediate Similarity NPD5404 Approved
0.7143 Intermediate Similarity NPD7199 Phase 2
0.7126 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD447 Suspended
0.7124 Intermediate Similarity NPD422 Phase 1
0.7117 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD6004 Phase 3
0.7117 Intermediate Similarity NPD6005 Phase 3
0.7117 Intermediate Similarity NPD6002 Phase 3
0.7099 Intermediate Similarity NPD4308 Phase 3
0.7099 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD9545 Approved
0.7078 Intermediate Similarity NPD1608 Approved
0.7077 Intermediate Similarity NPD8151 Discontinued
0.7073 Intermediate Similarity NPD2424 Discontinued
0.7066 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD5616 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD4288 Approved
0.7039 Intermediate Similarity NPD7177 Discontinued
0.7035 Intermediate Similarity NPD37 Approved
0.7029 Intermediate Similarity NPD6234 Discontinued
0.7019 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD6355 Discontinued
0.7019 Intermediate Similarity NPD5124 Phase 1
0.7016 Intermediate Similarity NPD6779 Approved
0.7016 Intermediate Similarity NPD6778 Approved
0.7016 Intermediate Similarity NPD6782 Approved
0.7016 Intermediate Similarity NPD6780 Approved
0.7016 Intermediate Similarity NPD6776 Approved
0.7016 Intermediate Similarity NPD6777 Approved
0.7016 Intermediate Similarity NPD6781 Approved
0.7011 Intermediate Similarity NPD4967 Phase 2
0.7011 Intermediate Similarity NPD4965 Approved
0.7011 Intermediate Similarity NPD4966 Approved
0.7006 Intermediate Similarity NPD3787 Discontinued
0.7006 Intermediate Similarity NPD1019 Discontinued
0.6994 Remote Similarity NPD8455 Phase 2
0.698 Remote Similarity NPD1241 Discontinued
0.6978 Remote Similarity NPD6104 Discontinued
0.6974 Remote Similarity NPD7584 Approved
0.6962 Remote Similarity NPD9494 Approved
0.6962 Remote Similarity NPD2861 Phase 2
0.6959 Remote Similarity NPD7871 Phase 2
0.6959 Remote Similarity NPD7870 Phase 2
0.6957 Remote Similarity NPD1613 Approved
0.6957 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6954 Remote Similarity NPD9493 Approved
0.6951 Remote Similarity NPD4477 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data